CollimateHealth

📍 München, Germany🗓 Founded 2026👥 11 employees💰 Last funded Jun 2026
Health and Human Services🌐 collimatehealth.com
Website LinkedIn
CollimateHealth develops a clinically scalable microbeam radiation technology designed to reshape the way cancer is treated. While conventional radiation oncology typically relies on broader and lower-dose beams that cause significant side effects, microbeam radiation delivers an array of extremely narrow, micrometre-scale beams at substantially higher dose. Tumors exposed to microbeam radiation undergo a form of highly disruptive cell death that increases antigen presentation, which helps to activate an immune response against cancer cells beyond the primary irradiated tumour. In addition, the temporary channels created by microbeam irradiation improve the delivery of therapeutics into tumour tissue, creating synergies with both chemotherapy and immunotherapy.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2026
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in CollimateHealth?
CollimateHealth has 1 investors on record on gritt.io, including 1 early-stage backers.
When did CollimateHealth last raise funding?
The most recent investment in CollimateHealth recorded on gritt.io was in June 2026.
When was CollimateHealth founded?
CollimateHealth was founded in 2026.
What industry is CollimateHealth in?
CollimateHealth operates in Health and Human Services. Find similar Health and Human Services investors on gritt.io.
Where is CollimateHealth based?
CollimateHealth is headquartered in München, Germany.